Researchers randomly assigned trial members to receive a placebo or 9 or 12 mg doses of retatrutide
It has an even longer duration of action than Toujeo, lasting up to 42 hours, which allows for more flexible injection timing
This triagonist mechanism is widely studied in metabolic and incretin-signaling research models, and in published clinical research has been associated with greater reductions than dual GLP-1/GIP agonists in comparable trials
Physical activity amplifies retatrutide results by preserving muscle mass during weight loss (critical for maintaining metabolic rate), increasing the caloric deficit beyond what appetite suppression alone achieves, and improving insulin sensitivity, which supports the metabolic effects of the medication
Fried foods, heavy sauces, creamy dishes, and fatty cuts of meat should be minimized on injection day
It activates three receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon